Skip to main content
Muller & Phipps (India) Ltd. logo

Muller & Phipps (India) Ltd. — Investor Relations & Filings

Ticker · 501477 ISIN · INE003F01015 BSE.NS Wholesale and retail trade
Filings indexed 248 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country IN India
Listing BSE.NS 501477

About Muller & Phipps (India) Ltd.

https://mulphico.swayantra.com/

Muller & Phipps (India) Ltd. focuses on the marketing and distribution of consumer healthcare, personal care, and home care products. The company manages a portfolio of established brands, including Sloan's Liniment and Nixoderm, specializing in over-the-counter pharmaceuticals and medicated skin care solutions. Its core operations involve managing complex supply chains and logistics networks to facilitate product placement across retail and pharmaceutical channels. The organization provides integrated brand management services, including sales strategy and distribution logistics, to ensure consistent market availability. By utilizing an extensive infrastructure and historical expertise in brand representation, the company serves as a key intermediary between manufacturing entities and the end-consumer market, maintaining a focus on quality and accessibility in its product range.

Recent filings

Filing Released Lang Actions
Muller & Phipps India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings Classification · 85% confidence The document is a formal notice to the stock exchange under SEBI Listing Regulations announcing the date of a Board Meeting to consider and take on record the audited financial statements. It does not contain the financial results or actual report itself, nor does it announce changes in management or any other specific corporate action category. This is a generic regulatory disclosure under listing rules, making it a Regulatory Filing (RNS) rather than the report itself or another more specific filing.
2026-05-15 English
We hereby enclosed the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31-03-2026
Regulatory Filings
2026-04-06 English
The Trading restriction period will commence from April 01, 2026 till 48 hours after the declaration of Audited Financial Results for the quarter and year ended 31-03-2026
Regulatory Filings
2026-03-25 English
Newspaper publication for unaudited Financial results for the quarter and nine months ended 31-12-2025
Regulatory Filings
2026-02-13 English
Results for the quarter and nine month ended 31-12-2025
Regulatory Filings
2026-02-11 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that the Board of Directors ....
Regulatory Filings
2026-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.